Positron emission tomography in non-medullary thyroid cancer

Ivan Ho Shon*, Barbara Depcynzski, Michael Lin, Jonathan R. Clark, Vincent Wong, Peter Lin, Peter Campbell

*Corresponding author for this work

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

While iodine scanning is the mainstay of functional imaging in differentiated thyroid cancer, there is now a significant body of literature regarding positron emission tomography with 2-fluoro-2-deoxy glucose in thyroid cancer. This clinical review will examine the evidence supporting the use of 2-fluoro-2-deoxy glucose-positron emission tomography throughout the diagnosis and management of thyroid cancer, and provide suggestions for its clinical use and potential future roles.

Original languageEnglish
Pages (from-to)116-124
Number of pages9
JournalANZ Journal of Surgery
Volume81
Issue number3
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

Keywords

  • Fluoro-deoxy glucose
  • Positron emission tomography
  • Thyroid neoplasm
  • Thyroid nodule

Fingerprint Dive into the research topics of 'Positron emission tomography in non-medullary thyroid cancer'. Together they form a unique fingerprint.

  • Cite this

    Ho Shon, I., Depcynzski, B., Lin, M., Clark, J. R., Wong, V., Lin, P., & Campbell, P. (2011). Positron emission tomography in non-medullary thyroid cancer. ANZ Journal of Surgery, 81(3), 116-124. https://doi.org/10.1111/j.1445-2197.2010.05538.x